Patricia Dorling

Company: Merck & Co

Job title: Senior Director - Value & Implementation Outcomes Research & Oncology

Seminars:

1:30 Integrating Real-World Evidence into Health Technology Assessments to Address Data Gaps & Drive Market Access Success 1:30 pm

 Standardize RWE data collection and reporting methods to reduce inconsistencies and improve the credibility of submissions to HTA bodies Use RWE to supplement clinical trial data, providing a more comprehensive view of a treatment’s real-world effectiveness, safety, and cost-effectiveness Foster collaboration between clinical, regulatory, and market access teams to ensure RWE aligns with HTA criteria…Read more

day: Day 1 PM pt2

9:00 Strategies to Streamline Collaboration, Accelerate Decision Making & Improve Real-World Evidence Acceptance Across Pharma, Regulators & Payers 9:00 am

Navigating payer and regulatory requirements in RWE is a high-stakes challenge, one missed step can mean delays, denied coverage, or wasted data. Regulators demand rigor, payers prioritize cost-effectiveness, yet their definitions of “acceptable evidence” rarely align. With evolving guidelines and increasing scrutiny, how can pharma generate the right data to bridge this gap? Unpack real-world case studies on…Read more

day: Pre-Conference Payers & Regulatory Alignment Day